Market capitalization | $5.98b |
Enterprise Value | $8.19b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 40.35 |
EV/Sales (TTM) EV/Sales | 3.44 |
P/S ratio (TTM) P/S ratio | 2.51 |
P/B ratio (TTM) P/B ratio | 2.12 |
Revenue growth (TTM) Revenue growth | 11.43% |
Revenue (TTM) Revenue | $2.38b |
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
12 Analysts have issued a R1 RCM Inc forecast:
12 Analysts have issued a R1 RCM Inc forecast:
Jun '24 |
+/-
%
|
||
Revenue | 2,380 2,380 |
11%
11%
|
|
Gross Profit | 483 483 |
17%
17%
|
|
EBITDA | 572 572 |
24%
24%
|
EBIT (Operating Income) EBIT | 271 271 |
46%
46%
|
Net Profit | -40 -40 |
39%
39%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL.
Head office | United States |
CEO | Lee Rivas |
Employees | 30,000 |
Founded | 2003 |
Website | www.r1rcm.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.